Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differentiating Benign and Malignant Pulmonary Nodules Using Epigenetically Modified Nucleosomes in Plasma

NCT06838806 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT06838806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06838806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Differentiating Benign and Malignant Pulmonary Nodules Using Epigenetically Modified Nucleosomes in Plasma
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 11, 2025
Completion date
March 31, 2026
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung nodule